Most founders can describe their ICP in five minutes. They cannot describe their anti-ICP at all. That asymmetry is a tell.
Every ICP document names who you serve. Almost no ICP documents name those you decline to serve. The anti-ICP is the harder document to write because it requires intellectual honesty — the discipline to look at a deal with a budget and a title and say: not this one. That kind of discipline does not come naturally to a sales-driven organization. It is acquired only after paying for its absence.
The anti-ICP protects three things: margin, deal velocity, and brand position. Every account that slips past the filter damages at least one of them.
The three archetypes your anti-ICP must name
The first is The Wrong Stage. This account looks like your ICP. It has a budget. It has the right title in the right function. But it sits two years away from the buying moment — either pre-PMF for what you sell, or running an evaluation to satisfy a board mandate they have no intent to act on. The deal will not close. It will, however, consume six weeks of AE time and show up in your forecast until it quietly disappears. The tell is a vague success criteria and a champion who cannot name the business problem the tool will solve.
The second is The Vampire. This account closes. It logs in twice. It churns at renewal. What makes the Vampire more destructive than a simple lost deal is what it does to the CS team on the way out — it drains hours at zero retention return while a healthier account waits for attention. Most teams claim they cannot spot Vampires in advance. The data disagrees. They almost always arrive through a procurement-led process with a junior champion and no executive sponsor who has a personal stake in the outcome.
The third is The Margin Killer. This account wins the deal at sixty percent of list. It demands a custom integration as a condition of signing. It references no one. And it sets a pricing precedent that every future deal in the segment will cite back to you. The revenue is real. The damage is larger than the revenue.
Why most teams never write the anti-ICP
The practical reason is pressure. A deal in forecast feels like progress, and disqualifying it feels like subtraction. The structural reason is that ICP work is typically done in the optimistic direction — who do we want? — and the anti-ICP requires working in the opposite direction, which is uncomfortable in a pipeline review.
The better framing: the anti-ICP is not a disqualification tool. It is a resource allocation tool. Every hour not spent on a Vampire is an hour available for the accounts that renew, expand, and refer. The anti-ICP makes that reallocation legible.
How to build yours
Pull your last twenty churned accounts. Pull your last ten deals that required more than thirty percent discount to close. Pull your last five deals that generated a formal complaint from CS within ninety days of onboarding. Look for the patterns — stage, buying process structure, champion seniority, deal velocity, integration demands. The anti-ICP archetypes are already in your closed-lost and post-churn data. The work is naming them explicitly enough that an AE can recognize one in the first discovery call.
The ICP tells your team who to pursue. The anti-ICP tells your team who to let go of before it costs more than it is worth. Both documents belong in every GTM packet you hand to a new rep.
Want to build your anti-ICP from your own closed-lost data?
We covered the full framework — including how to identify all three archetypes and write the document your sales team will actually use — in our latest webinar, 5 Things That Separate an ICP That Fails from One That Scales.
WANT US TO MAKE YOU A CUSTOM BUILT GTM PLAN?
Apply Now